ArticleInternational journal of cardiology. Cardiovascular risk and prevention2025
Sex-specific global burden of cardiometabolic and respiratory diseases attributable to secondhand smoke exposure: Insights from the global burden of disease study 2021.
Article in International journal of cardiology. Cardiovascular risk and prevention, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluating the DALY impact of disease associated with second-hand smoke exposure in different socio-demographic index regions.Substance abuse treatment, prevention, and policy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To quantify sex and sociodemographic-specific burdens of cardiometabolic and respiratory diseases attributable to secondhand smoke (SHS) using GBD 2021 data. Study design: Global Burden of Disease (GBD)-based secondary data analysis. Methods: We used sex-disaggregated GBD 2021 estimates (1990-2021) to calculate population attributable fractions (PAFs), cause-specific death rates, and cause-specific DALY rates, and to examine exposure-burden relationships across Socio-demographic Index (SDI) strata. Results: PAFs and exposure declined overall, but heterogeneity persisted by sex and SDI. Females had higher PAFs for COPD and diabetes. Diabetes PAF in females rose slightly from 3.9 % (95 % UI: 1.4-6.4) to 4.0 % (95 % UI: 1.4-6.6). Absolute burdens support these patterns: in 2021 female COPD cause-specific DALY rate was 874.96 (95 % UI: 697.60-1092.43) versus male 606.07 (95 % UI: 490.75-755.31); male IHD death rate was 235.12 (95 % UI: 187.74-296.26) versus female 153.61 (95 % UI: 125.33-192.42). Low- and middle-SDI regions retained the largest burden per unit exposure. Conclusions: Sex differences in SHS-attributable burden persist and vary by SDI; policy responses should be sex- and context-specific.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.